nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—ABCB1—Liothyronine—hypothyroidism	0.124	0.28	CbGbCtD
Sertraline—ABCB1—Levothyroxine—hypothyroidism	0.124	0.28	CbGbCtD
Sertraline—ABCB1—Liotrix—hypothyroidism	0.121	0.273	CbGbCtD
Sertraline—CYP3A4—Levothyroxine—hypothyroidism	0.0745	0.168	CbGbCtD
Sertraline—Serum sickness—Dextrothyroxine—hypothyroidism	0.00936	0.0255	CcSEcCtD
Sertraline—Serum sickness—Levothyroxine—hypothyroidism	0.00936	0.0255	CcSEcCtD
Sertraline—Muscle twitching—Liothyronine—hypothyroidism	0.00911	0.0248	CcSEcCtD
Sertraline—CYP2C19—urine—hypothyroidism	0.00872	0.0514	CbGeAlD
Sertraline—Menstruation irregular—Levothyroxine—hypothyroidism	0.00793	0.0216	CcSEcCtD
Sertraline—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00793	0.0216	CcSEcCtD
Sertraline—SLC6A3—nerve—hypothyroidism	0.00792	0.0467	CbGeAlD
Sertraline—CYP1A2—urine—hypothyroidism	0.00712	0.042	CbGeAlD
Sertraline—MAOB—nerve—hypothyroidism	0.0069	0.0407	CbGeAlD
Sertraline—Serum sickness—Liotrix—hypothyroidism	0.00689	0.0187	CcSEcCtD
Sertraline—CYP2C9—urine—hypothyroidism	0.00676	0.0398	CbGeAlD
Sertraline—SLC6A2—nerve—hypothyroidism	0.00639	0.0377	CbGeAlD
Sertraline—MAOA—nerve—hypothyroidism	0.00589	0.0347	CbGeAlD
Sertraline—Menstruation irregular—Liotrix—hypothyroidism	0.00583	0.0159	CcSEcCtD
Sertraline—CYP3A4—urine—hypothyroidism	0.00515	0.0304	CbGeAlD
Sertraline—CYP2D6—urine—hypothyroidism	0.00507	0.0299	CbGeAlD
Sertraline—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00493	0.0134	CcSEcCtD
Sertraline—Myocardial infarction—Liothyronine—hypothyroidism	0.0049	0.0133	CcSEcCtD
Sertraline—Necrosis—Liotrix—hypothyroidism	0.00412	0.0112	CcSEcCtD
Sertraline—Coma—Dextrothyroxine—hypothyroidism	0.00401	0.0109	CcSEcCtD
Sertraline—Coma—Levothyroxine—hypothyroidism	0.00401	0.0109	CcSEcCtD
Sertraline—Arrhythmia—Liothyronine—hypothyroidism	0.00401	0.0109	CcSEcCtD
Sertraline—Hyperkinesia—Levothyroxine—hypothyroidism	0.00383	0.0104	CcSEcCtD
Sertraline—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00383	0.0104	CcSEcCtD
Sertraline—Oliguria—Liotrix—hypothyroidism	0.0035	0.00953	CcSEcCtD
Sertraline—Increased appetite—Levothyroxine—hypothyroidism	0.00339	0.00923	CcSEcCtD
Sertraline—Increased appetite—Dextrothyroxine—hypothyroidism	0.00339	0.00923	CcSEcCtD
Sertraline—Hypertension—Liothyronine—hypothyroidism	0.00337	0.00918	CcSEcCtD
Sertraline—Muscle twitching—Liotrix—hypothyroidism	0.00329	0.00894	CcSEcCtD
Sertraline—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00327	0.00888	CcSEcCtD
Sertraline—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00327	0.00888	CcSEcCtD
Sertraline—Affect lability—Levothyroxine—hypothyroidism	0.00314	0.00853	CcSEcCtD
Sertraline—Affect lability—Dextrothyroxine—hypothyroidism	0.00314	0.00853	CcSEcCtD
Sertraline—Tachycardia—Liothyronine—hypothyroidism	0.00311	0.00847	CcSEcCtD
Sertraline—Fluid retention—Liotrix—hypothyroidism	0.00307	0.00834	CcSEcCtD
Sertraline—Mood swings—Dextrothyroxine—hypothyroidism	0.00302	0.00821	CcSEcCtD
Sertraline—Mood swings—Levothyroxine—hypothyroidism	0.00302	0.00821	CcSEcCtD
Sertraline—Hypotension—Liothyronine—hypothyroidism	0.00298	0.00811	CcSEcCtD
Sertraline—Dehydration—Dextrothyroxine—hypothyroidism	0.00296	0.00806	CcSEcCtD
Sertraline—Dehydration—Levothyroxine—hypothyroidism	0.00296	0.00806	CcSEcCtD
Sertraline—Coma—Liotrix—hypothyroidism	0.00295	0.00803	CcSEcCtD
Sertraline—Hyperkinesia—Liotrix—hypothyroidism	0.00282	0.00766	CcSEcCtD
Sertraline—Muscular weakness—Levothyroxine—hypothyroidism	0.00281	0.00764	CcSEcCtD
Sertraline—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00281	0.00764	CcSEcCtD
Sertraline—SIGMAR1—adrenal cortex—hypothyroidism	0.00277	0.0163	CbGeAlD
Sertraline—Dysphagia—Levothyroxine—hypothyroidism	0.00275	0.00749	CcSEcCtD
Sertraline—Dysphagia—Dextrothyroxine—hypothyroidism	0.00275	0.00749	CcSEcCtD
Sertraline—Sweating increased—Levothyroxine—hypothyroidism	0.00268	0.0073	CcSEcCtD
Sertraline—Sweating increased—Dextrothyroxine—hypothyroidism	0.00268	0.0073	CcSEcCtD
Sertraline—SIGMAR1—heart—hypothyroidism	0.00268	0.0158	CbGeAlD
Sertraline—MAOB—adrenal cortex—hypothyroidism	0.00265	0.0156	CbGeAlD
Sertraline—MAOB—heart—hypothyroidism	0.00256	0.0151	CbGeAlD
Sertraline—Renal failure acute—Liotrix—hypothyroidism	0.00254	0.00691	CcSEcCtD
Sertraline—Body temperature increased—Liothyronine—hypothyroidism	0.00252	0.00686	CcSEcCtD
Sertraline—Increased appetite—Liotrix—hypothyroidism	0.0025	0.00679	CcSEcCtD
Sertraline—Weight decreased—Levothyroxine—hypothyroidism	0.00249	0.00678	CcSEcCtD
Sertraline—Weight decreased—Dextrothyroxine—hypothyroidism	0.00249	0.00678	CcSEcCtD
Sertraline—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00242	0.00658	CcSEcCtD
Sertraline—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00242	0.00658	CcSEcCtD
Sertraline—MAOB—cardiovascular system—hypothyroidism	0.00242	0.0142	CbGeAlD
Sertraline—Myocardial infarction—Levothyroxine—hypothyroidism	0.00241	0.00655	CcSEcCtD
Sertraline—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00241	0.00655	CcSEcCtD
Sertraline—Hypoglycaemia—Liotrix—hypothyroidism	0.0024	0.00653	CcSEcCtD
Sertraline—Sweating—Dextrothyroxine—hypothyroidism	0.00235	0.0064	CcSEcCtD
Sertraline—Sweating—Levothyroxine—hypothyroidism	0.00235	0.0064	CcSEcCtD
Sertraline—Affect lability—Liotrix—hypothyroidism	0.00231	0.00628	CcSEcCtD
Sertraline—MAOA—adrenal cortex—hypothyroidism	0.00226	0.0133	CbGeAlD
Sertraline—SIGMAR1—pituitary gland—hypothyroidism	0.00224	0.0132	CbGeAlD
Sertraline—Mood swings—Liotrix—hypothyroidism	0.00222	0.00604	CcSEcCtD
Sertraline—MAOA—heart—hypothyroidism	0.00219	0.0129	CbGeAlD
Sertraline—Dehydration—Liotrix—hypothyroidism	0.00218	0.00593	CcSEcCtD
Sertraline—MAOB—pituitary gland—hypothyroidism	0.00214	0.0126	CbGeAlD
Sertraline—Muscular weakness—Liotrix—hypothyroidism	0.00207	0.00562	CcSEcCtD
Sertraline—MAOA—cardiovascular system—hypothyroidism	0.00206	0.0122	CbGeAlD
Sertraline—Flushing—Levothyroxine—hypothyroidism	0.00205	0.00557	CcSEcCtD
Sertraline—Flushing—Dextrothyroxine—hypothyroidism	0.00205	0.00557	CcSEcCtD
Sertraline—Abdominal distension—Liotrix—hypothyroidism	0.00204	0.00555	CcSEcCtD
Sertraline—SLC6A2—gonad—hypothyroidism	0.00203	0.012	CbGeAlD
Sertraline—Dysphagia—Liotrix—hypothyroidism	0.00203	0.00551	CcSEcCtD
Sertraline—SLC6A4—blood—hypothyroidism	0.00201	0.0119	CbGeAlD
Sertraline—SIGMAR1—adrenal gland—hypothyroidism	0.002	0.0118	CbGeAlD
Sertraline—SIGMAR1—blood—hypothyroidism	0.002	0.0118	CbGeAlD
Sertraline—Bronchospasm—Liotrix—hypothyroidism	0.00199	0.00542	CcSEcCtD
Sertraline—Sweating increased—Liotrix—hypothyroidism	0.00197	0.00537	CcSEcCtD
Sertraline—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00197	0.00536	CcSEcCtD
Sertraline—Arrhythmia—Levothyroxine—hypothyroidism	0.00197	0.00536	CcSEcCtD
Sertraline—Bronchitis—Liotrix—hypothyroidism	0.00195	0.0053	CcSEcCtD
Sertraline—Alopecia—Dextrothyroxine—hypothyroidism	0.00195	0.0053	CcSEcCtD
Sertraline—Alopecia—Levothyroxine—hypothyroidism	0.00195	0.0053	CcSEcCtD
Sertraline—SIGMAR1—thyroid gland—hypothyroidism	0.00193	0.0114	CbGeAlD
Sertraline—MAOB—adrenal gland—hypothyroidism	0.00191	0.0113	CbGeAlD
Sertraline—MAOB—blood—hypothyroidism	0.00191	0.0113	CbGeAlD
Sertraline—Tension—Dextrothyroxine—hypothyroidism	0.00188	0.00512	CcSEcCtD
Sertraline—Tension—Levothyroxine—hypothyroidism	0.00188	0.00512	CcSEcCtD
Sertraline—Nervousness—Dextrothyroxine—hypothyroidism	0.00186	0.00507	CcSEcCtD
Sertraline—Nervousness—Levothyroxine—hypothyroidism	0.00186	0.00507	CcSEcCtD
Sertraline—SIGMAR1—female gonad—hypothyroidism	0.00186	0.011	CbGeAlD
Sertraline—MAOB—thyroid gland—hypothyroidism	0.00185	0.0109	CbGeAlD
Sertraline—Weight decreased—Liotrix—hypothyroidism	0.00183	0.00499	CcSEcCtD
Sertraline—MAOA—pituitary gland—hypothyroidism	0.00183	0.0108	CbGeAlD
Sertraline—SLC6A3—testis—hypothyroidism	0.00182	0.0107	CbGeAlD
Sertraline—CYP2B6—adrenal cortex—hypothyroidism	0.00181	0.0107	CbGeAlD
Sertraline—Tremor—Levothyroxine—hypothyroidism	0.0018	0.00489	CcSEcCtD
Sertraline—Tremor—Dextrothyroxine—hypothyroidism	0.0018	0.00489	CcSEcCtD
Sertraline—MAOB—female gonad—hypothyroidism	0.00178	0.0105	CbGeAlD
Sertraline—Acute coronary syndrome—Liotrix—hypothyroidism	0.00178	0.00484	CcSEcCtD
Sertraline—Myocardial infarction—Liotrix—hypothyroidism	0.00177	0.00482	CcSEcCtD
Sertraline—SLC6A2—adrenal gland—hypothyroidism	0.00177	0.0104	CbGeAlD
Sertraline—Agitation—Dextrothyroxine—hypothyroidism	0.00176	0.0048	CcSEcCtD
Sertraline—Agitation—Levothyroxine—hypothyroidism	0.00176	0.0048	CcSEcCtD
Sertraline—Angioedema—Dextrothyroxine—hypothyroidism	0.00175	0.00477	CcSEcCtD
Sertraline—Angioedema—Levothyroxine—hypothyroidism	0.00175	0.00477	CcSEcCtD
Sertraline—CYP2B6—heart—hypothyroidism	0.00175	0.0103	CbGeAlD
Sertraline—Sweating—Liotrix—hypothyroidism	0.00173	0.00471	CcSEcCtD
Sertraline—CYP2C9—heart—hypothyroidism	0.00173	0.0102	CbGeAlD
Sertraline—Palpitations—Levothyroxine—hypothyroidism	0.0017	0.00461	CcSEcCtD
Sertraline—Palpitations—Dextrothyroxine—hypothyroidism	0.0017	0.00461	CcSEcCtD
Sertraline—SLC6A3—cerebellum—hypothyroidism	0.00168	0.00988	CbGeAlD
Sertraline—CYP2C19—blood—hypothyroidism	0.00167	0.00982	CbGeAlD
Sertraline—Convulsion—Dextrothyroxine—hypothyroidism	0.00166	0.00452	CcSEcCtD
Sertraline—Convulsion—Levothyroxine—hypothyroidism	0.00166	0.00452	CcSEcCtD
Sertraline—SIGMAR1—testis—hypothyroidism	0.00165	0.00974	CbGeAlD
Sertraline—CYP2B6—cardiovascular system—hypothyroidism	0.00165	0.00972	CbGeAlD
Sertraline—Arthralgia—Levothyroxine—hypothyroidism	0.00163	0.00444	CcSEcCtD
Sertraline—Arthralgia—Dextrothyroxine—hypothyroidism	0.00163	0.00444	CcSEcCtD
Sertraline—CYP2C9—cardiovascular system—hypothyroidism	0.00163	0.00963	CbGeAlD
Sertraline—MAOA—adrenal gland—hypothyroidism	0.00163	0.00962	CbGeAlD
Sertraline—MAOA—blood—hypothyroidism	0.00163	0.00961	CbGeAlD
Sertraline—Anxiety—Levothyroxine—hypothyroidism	0.00163	0.00443	CcSEcCtD
Sertraline—Anxiety—Dextrothyroxine—hypothyroidism	0.00163	0.00443	CcSEcCtD
Sertraline—Hypoaesthesia—Liotrix—hypothyroidism	0.00161	0.00439	CcSEcCtD
Sertraline—MAOB—testis—hypothyroidism	0.00158	0.00932	CbGeAlD
Sertraline—Confusional state—Dextrothyroxine—hypothyroidism	0.00158	0.0043	CcSEcCtD
Sertraline—Confusional state—Levothyroxine—hypothyroidism	0.00158	0.0043	CcSEcCtD
Sertraline—MAOA—thyroid gland—hypothyroidism	0.00157	0.00928	CbGeAlD
Sertraline—SIGMAR1—liver—hypothyroidism	0.00156	0.00921	CbGeAlD
Sertraline—Shock—Dextrothyroxine—hypothyroidism	0.00154	0.00419	CcSEcCtD
Sertraline—Shock—Levothyroxine—hypothyroidism	0.00154	0.00419	CcSEcCtD
Sertraline—Tachycardia—Levothyroxine—hypothyroidism	0.00153	0.00416	CcSEcCtD
Sertraline—Tachycardia—Dextrothyroxine—hypothyroidism	0.00153	0.00416	CcSEcCtD
Sertraline—SIGMAR1—cerebellum—hypothyroidism	0.00153	0.00899	CbGeAlD
Sertraline—MAOA—female gonad—hypothyroidism	0.00152	0.00897	CbGeAlD
Sertraline—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00151	0.00412	CcSEcCtD
Sertraline—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00151	0.00412	CcSEcCtD
Sertraline—Flushing—Liotrix—hypothyroidism	0.00151	0.00409	CcSEcCtD
Sertraline—CYP2B6—gonad—hypothyroidism	0.0015	0.00882	CbGeAlD
Sertraline—MAOB—liver—hypothyroidism	0.0015	0.00881	CbGeAlD
Sertraline—SLC6A2—testis—hypothyroidism	0.00146	0.00863	CbGeAlD
Sertraline—MAOB—cerebellum—hypothyroidism	0.00146	0.00861	CbGeAlD
Sertraline—Arrhythmia—Liotrix—hypothyroidism	0.00145	0.00394	CcSEcCtD
Sertraline—Alopecia—Liotrix—hypothyroidism	0.00143	0.0039	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00143	0.00388	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00143	0.00388	CcSEcCtD
Sertraline—Insomnia—Dextrothyroxine—hypothyroidism	0.00142	0.00385	CcSEcCtD
Sertraline—Insomnia—Levothyroxine—hypothyroidism	0.00142	0.00385	CcSEcCtD
Sertraline—Dyspnoea—Dextrothyroxine—hypothyroidism	0.0014	0.0038	CcSEcCtD
Sertraline—Dyspnoea—Levothyroxine—hypothyroidism	0.0014	0.0038	CcSEcCtD
Sertraline—Flatulence—Liotrix—hypothyroidism	0.00139	0.00378	CcSEcCtD
Sertraline—Tension—Liotrix—hypothyroidism	0.00139	0.00377	CcSEcCtD
Sertraline—Dysgeusia—Liotrix—hypothyroidism	0.00138	0.00376	CcSEcCtD
Sertraline—Nervousness—Liotrix—hypothyroidism	0.00137	0.00373	CcSEcCtD
Sertraline—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00137	0.076	CbGpPWpGaD
Sertraline—CYP1A2—blood—hypothyroidism	0.00136	0.00802	CbGeAlD
Sertraline—Fatigue—Dextrothyroxine—hypothyroidism	0.00135	0.00367	CcSEcCtD
Sertraline—Fatigue—Levothyroxine—hypothyroidism	0.00135	0.00367	CcSEcCtD
Sertraline—MAOA—testis—hypothyroidism	0.00135	0.00795	CbGeAlD
Sertraline—Tremor—Liotrix—hypothyroidism	0.00132	0.0036	CcSEcCtD
Sertraline—CYP1A2—thyroid gland—hypothyroidism	0.00131	0.00774	CbGeAlD
Sertraline—CYP2B6—adrenal gland—hypothyroidism	0.0013	0.00769	CbGeAlD
Sertraline—CYP2B6—blood—hypothyroidism	0.0013	0.00769	CbGeAlD
Sertraline—CYP2C19—liver—hypothyroidism	0.0013	0.00768	CbGeAlD
Sertraline—Agitation—Liotrix—hypothyroidism	0.0013	0.00353	CcSEcCtD
Sertraline—CYP2C9—blood—hypothyroidism	0.00129	0.00761	CbGeAlD
Sertraline—Feeling abnormal—Levothyroxine—hypothyroidism	0.00129	0.00351	CcSEcCtD
Sertraline—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00129	0.00351	CcSEcCtD
Sertraline—Angioedema—Liotrix—hypothyroidism	0.00129	0.00351	CcSEcCtD
Sertraline—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00128	0.00348	CcSEcCtD
Sertraline—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00128	0.00348	CcSEcCtD
Sertraline—MAOA—liver—hypothyroidism	0.00128	0.00752	CbGeAlD
Sertraline—Syncope—Liotrix—hypothyroidism	0.00127	0.00344	CcSEcCtD
Sertraline—Palpitations—Liotrix—hypothyroidism	0.00125	0.00339	CcSEcCtD
Sertraline—MAOA—cerebellum—hypothyroidism	0.00125	0.00734	CbGeAlD
Sertraline—Urticaria—Dextrothyroxine—hypothyroidism	0.00124	0.00338	CcSEcCtD
Sertraline—Urticaria—Levothyroxine—hypothyroidism	0.00124	0.00338	CcSEcCtD
Sertraline—Loss of consciousness—Liotrix—hypothyroidism	0.00124	0.00337	CcSEcCtD
Sertraline—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00124	0.0688	CbGpPWpGaD
Sertraline—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00124	0.00337	CcSEcCtD
Sertraline—Body temperature increased—Levothyroxine—hypothyroidism	0.00124	0.00337	CcSEcCtD
Sertraline—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00124	0.00337	CcSEcCtD
Sertraline—Abdominal pain—Levothyroxine—hypothyroidism	0.00124	0.00337	CcSEcCtD
Sertraline—Convulsion—Liotrix—hypothyroidism	0.00122	0.00333	CcSEcCtD
Sertraline—Hypertension—Liotrix—hypothyroidism	0.00122	0.00331	CcSEcCtD
Sertraline—Chest pain—Liotrix—hypothyroidism	0.0012	0.00327	CcSEcCtD
Sertraline—Arthralgia—Liotrix—hypothyroidism	0.0012	0.00327	CcSEcCtD
Sertraline—Anxiety—Liotrix—hypothyroidism	0.0012	0.00326	CcSEcCtD
Sertraline—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00118	0.0653	CbGpPWpGaD
Sertraline—Confusional state—Liotrix—hypothyroidism	0.00116	0.00316	CcSEcCtD
Sertraline—Oedema—Liotrix—hypothyroidism	0.00115	0.00313	CcSEcCtD
Sertraline—Anaphylactic shock—Liotrix—hypothyroidism	0.00115	0.00313	CcSEcCtD
Sertraline—Shock—Liotrix—hypothyroidism	0.00113	0.00308	CcSEcCtD
Sertraline—Tachycardia—Liotrix—hypothyroidism	0.00112	0.00306	CcSEcCtD
Sertraline—Asthenia—Levothyroxine—hypothyroidism	0.00112	0.00306	CcSEcCtD
Sertraline—Asthenia—Dextrothyroxine—hypothyroidism	0.00112	0.00306	CcSEcCtD
Sertraline—Hyperhidrosis—Liotrix—hypothyroidism	0.00111	0.00303	CcSEcCtD
Sertraline—Pruritus—Dextrothyroxine—hypothyroidism	0.00111	0.00301	CcSEcCtD
Sertraline—Pruritus—Levothyroxine—hypothyroidism	0.00111	0.00301	CcSEcCtD
Sertraline—Anorexia—Liotrix—hypothyroidism	0.0011	0.00299	CcSEcCtD
Sertraline—SLC6A3—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0011	0.061	CbGpPWpGaD
Sertraline—CYP2B6—testis—hypothyroidism	0.00108	0.00636	CbGeAlD
Sertraline—Hypotension—Liotrix—hypothyroidism	0.00108	0.00293	CcSEcCtD
Sertraline—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00107	0.00291	CcSEcCtD
Sertraline—Diarrhoea—Levothyroxine—hypothyroidism	0.00107	0.00291	CcSEcCtD
Sertraline—CYP1A2—liver—hypothyroidism	0.00106	0.00627	CbGeAlD
Sertraline—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00105	0.00285	CcSEcCtD
Sertraline—SLC6A3—Monoamine Transport—SLC5A7—hypothyroidism	0.00104	0.0579	CbGpPWpGaD
Sertraline—Insomnia—Liotrix—hypothyroidism	0.00104	0.00283	CcSEcCtD
Sertraline—Paraesthesia—Liotrix—hypothyroidism	0.00103	0.00281	CcSEcCtD
Sertraline—Dyspnoea—Liotrix—hypothyroidism	0.00103	0.00279	CcSEcCtD
Sertraline—CYP2B6—liver—hypothyroidism	0.00102	0.00601	CbGeAlD
Sertraline—CYP2C9—liver—hypothyroidism	0.00101	0.00595	CbGeAlD
Sertraline—Decreased appetite—Liotrix—hypothyroidism	0.001	0.00272	CcSEcCtD
Sertraline—Vomiting—Levothyroxine—hypothyroidism	0.000996	0.00271	CcSEcCtD
Sertraline—Vomiting—Dextrothyroxine—hypothyroidism	0.000996	0.00271	CcSEcCtD
Sertraline—Fatigue—Liotrix—hypothyroidism	0.000994	0.0027	CcSEcCtD
Sertraline—Rash—Dextrothyroxine—hypothyroidism	0.000988	0.00269	CcSEcCtD
Sertraline—Rash—Levothyroxine—hypothyroidism	0.000988	0.00269	CcSEcCtD
Sertraline—Dermatitis—Levothyroxine—hypothyroidism	0.000987	0.00268	CcSEcCtD
Sertraline—Dermatitis—Dextrothyroxine—hypothyroidism	0.000987	0.00268	CcSEcCtD
Sertraline—Constipation—Liotrix—hypothyroidism	0.000985	0.00268	CcSEcCtD
Sertraline—CYP3A4—blood—hypothyroidism	0.000985	0.00581	CbGeAlD
Sertraline—Headache—Levothyroxine—hypothyroidism	0.000981	0.00267	CcSEcCtD
Sertraline—Headache—Dextrothyroxine—hypothyroidism	0.000981	0.00267	CcSEcCtD
Sertraline—CYP2D6—blood—hypothyroidism	0.000969	0.00571	CbGeAlD
Sertraline—ABCB1—adrenal cortex—hypothyroidism	0.000966	0.00569	CbGeAlD
Sertraline—Feeling abnormal—Liotrix—hypothyroidism	0.00095	0.00258	CcSEcCtD
Sertraline—Gastrointestinal pain—Liotrix—hypothyroidism	0.000942	0.00256	CcSEcCtD
Sertraline—ABCB1—heart—hypothyroidism	0.000934	0.00551	CbGeAlD
Sertraline—Nausea—Levothyroxine—hypothyroidism	0.000931	0.00253	CcSEcCtD
Sertraline—Nausea—Dextrothyroxine—hypothyroidism	0.000931	0.00253	CcSEcCtD
Sertraline—Urticaria—Liotrix—hypothyroidism	0.000915	0.00249	CcSEcCtD
Sertraline—Body temperature increased—Liotrix—hypothyroidism	0.000911	0.00248	CcSEcCtD
Sertraline—Abdominal pain—Liotrix—hypothyroidism	0.000911	0.00248	CcSEcCtD
Sertraline—CYP2D6—female gonad—hypothyroidism	0.000904	0.00533	CbGeAlD
Sertraline—MAOA—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.000903	0.0501	CbGpPWpGaD
Sertraline—ABCB1—cardiovascular system—hypothyroidism	0.000882	0.0052	CbGeAlD
Sertraline—Hypersensitivity—Liotrix—hypothyroidism	0.000849	0.00231	CcSEcCtD
Sertraline—Asthenia—Liotrix—hypothyroidism	0.000827	0.00225	CcSEcCtD
Sertraline—Pruritus—Liotrix—hypothyroidism	0.000815	0.00222	CcSEcCtD
Sertraline—CYP2D6—testis—hypothyroidism	0.000802	0.00473	CbGeAlD
Sertraline—ABCB1—gonad—hypothyroidism	0.0008	0.00472	CbGeAlD
Sertraline—Diarrhoea—Liotrix—hypothyroidism	0.000788	0.00214	CcSEcCtD
Sertraline—ABCB1—pituitary gland—hypothyroidism	0.000781	0.0046	CbGeAlD
Sertraline—CYP3A4—liver—hypothyroidism	0.00077	0.00454	CbGeAlD
Sertraline—Dizziness—Liotrix—hypothyroidism	0.000762	0.00207	CcSEcCtD
Sertraline—CYP2D6—liver—hypothyroidism	0.000758	0.00447	CbGeAlD
Sertraline—CYP2D6—cerebellum—hypothyroidism	0.000741	0.00436	CbGeAlD
Sertraline—Vomiting—Liotrix—hypothyroidism	0.000733	0.00199	CcSEcCtD
Sertraline—Rash—Liotrix—hypothyroidism	0.000727	0.00198	CcSEcCtD
Sertraline—Dermatitis—Liotrix—hypothyroidism	0.000726	0.00197	CcSEcCtD
Sertraline—Headache—Liotrix—hypothyroidism	0.000722	0.00196	CcSEcCtD
Sertraline—ABCB1—adrenal gland—hypothyroidism	0.000697	0.00411	CbGeAlD
Sertraline—ABCB1—blood—hypothyroidism	0.000697	0.00411	CbGeAlD
Sertraline—Nausea—Liotrix—hypothyroidism	0.000685	0.00186	CcSEcCtD
Sertraline—ABCB1—thyroid gland—hypothyroidism	0.000673	0.00397	CbGeAlD
Sertraline—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.000653	0.0363	CbGpPWpGaD
Sertraline—ABCB1—female gonad—hypothyroidism	0.00065	0.00383	CbGeAlD
Sertraline—ABCB1—testis—hypothyroidism	0.000577	0.0034	CbGeAlD
Sertraline—ABCB1—liver—hypothyroidism	0.000545	0.00321	CbGeAlD
Sertraline—ABCB1—cerebellum—hypothyroidism	0.000533	0.00314	CbGeAlD
Sertraline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000485	0.0269	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000473	0.0263	CbGpPWpGaD
Sertraline—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000429	0.0238	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.000406	0.0226	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000388	0.0215	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00035	0.0194	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—SLC5A7—hypothyroidism	0.00031	0.0172	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000305	0.0169	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000261	0.0145	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000259	0.0144	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00025	0.0139	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000241	0.0134	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00022	0.0122	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—SLC5A7—hypothyroidism	0.000198	0.011	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000195	0.0108	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.000184	0.0102	CbGpPWpGaD
Sertraline—MAOB—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000183	0.0102	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000183	0.0101	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000167	0.00927	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000162	0.00902	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000162	0.00898	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000155	0.00861	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.00014	0.00776	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—NEFL—hypothyroidism	0.000128	0.0071	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000124	0.00687	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000121	0.00673	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000119	0.0066	CbGpPWpGaD
Sertraline—MAOA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000115	0.00639	CbGpPWpGaD
Sertraline—MAOB—Metabolism—IYD—hypothyroidism	0.000115	0.00638	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000112	0.00621	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—AVP—hypothyroidism	9.94e-05	0.00552	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.92e-05	0.00551	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	9.9e-05	0.0055	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ATP5O—hypothyroidism	9.77e-05	0.00542	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—POMC—hypothyroidism	9.74e-05	0.00541	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.27e-05	0.00515	CbGpPWpGaD
Sertraline—MAOB—Metabolism—TPO—hypothyroidism	9.18e-05	0.0051	CbGpPWpGaD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.89e-05	0.00493	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	8.8e-05	0.00489	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	8.22e-05	0.00456	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	7.8e-05	0.00433	CbGpPWpGaD
Sertraline—MAOA—Metabolism—IYD—hypothyroidism	7.21e-05	0.004	CbGpPWpGaD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.21e-05	0.004	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.93e-05	0.00385	CbGpPWpGaD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.72e-05	0.00373	CbGpPWpGaD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.18e-05	0.00343	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	6.14e-05	0.00341	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ATP5O—hypothyroidism	6.13e-05	0.0034	CbGpPWpGaD
Sertraline—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.12e-05	0.0034	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—POMC—hypothyroidism	6.11e-05	0.00339	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TPO—hypothyroidism	5.76e-05	0.0032	CbGpPWpGaD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.44e-05	0.00302	CbGpPWpGaD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.23e-05	0.00291	CbGpPWpGaD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.01e-05	0.00278	CbGpPWpGaD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.96e-05	0.00276	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	4.93e-05	0.00274	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—IYD—hypothyroidism	4.52e-05	0.00251	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.47e-05	0.00248	CbGpPWpGaD
Sertraline—MAOB—Metabolism—TSHB—hypothyroidism	4.25e-05	0.00236	CbGpPWpGaD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.24e-05	0.00236	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.08e-05	0.00227	CbGpPWpGaD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.04e-05	0.00224	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.96e-05	0.0022	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ATP5O—hypothyroidism	3.84e-05	0.00213	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—POMC—hypothyroidism	3.83e-05	0.00212	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3C2A—hypothyroidism	3.79e-05	0.0021	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TPO—hypothyroidism	3.61e-05	0.002	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	3.52e-05	0.00196	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—IYD—hypothyroidism	3.41e-05	0.00189	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—IYD—hypothyroidism	3.33e-05	0.00185	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.27e-05	0.00182	CbGpPWpGaD
Sertraline—MAOB—Metabolism—SLC5A5—hypothyroidism	3.18e-05	0.00177	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—IYD—hypothyroidism	3.14e-05	0.00174	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	3.12e-05	0.00173	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—IYD—hypothyroidism	3.11e-05	0.00173	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ATP5O—hypothyroidism	2.9e-05	0.00161	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—POMC—hypothyroidism	2.89e-05	0.00161	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ATP5O—hypothyroidism	2.83e-05	0.00157	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TPO—hypothyroidism	2.73e-05	0.00151	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ATP5O—hypothyroidism	2.67e-05	0.00148	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TSHB—hypothyroidism	2.67e-05	0.00148	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TPO—hypothyroidism	2.66e-05	0.00148	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—POMC—hypothyroidism	2.66e-05	0.00148	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—IYD—hypothyroidism	2.66e-05	0.00148	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ATP5O—hypothyroidism	2.65e-05	0.00147	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—POMC—hypothyroidism	2.64e-05	0.00146	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.53e-05	0.0014	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TPO—hypothyroidism	2.51e-05	0.00139	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.5e-05	0.00139	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TPO—hypothyroidism	2.49e-05	0.00138	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3C2A—hypothyroidism	2.38e-05	0.00132	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.3e-05	0.00128	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ATP5O—hypothyroidism	2.26e-05	0.00126	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—POMC—hypothyroidism	2.25e-05	0.00125	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TPO—hypothyroidism	2.13e-05	0.00118	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—IYD—hypothyroidism	2.05e-05	0.00114	CbGpPWpGaD
Sertraline—MAOA—Metabolism—SLC5A5—hypothyroidism	2e-05	0.00111	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.97e-05	0.00109	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.97e-05	0.00109	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.74e-05	0.000969	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.74e-05	0.000966	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TSHB—hypothyroidism	1.67e-05	0.000928	CbGpPWpGaD
Sertraline—MAOB—Metabolism—POMC—hypothyroidism	1.67e-05	0.000925	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TPO—hypothyroidism	1.64e-05	0.000911	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.55e-05	0.000861	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	1.49e-05	0.000827	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TSHB—hypothyroidism	1.26e-05	0.000701	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SLC5A5—hypothyroidism	1.25e-05	0.000695	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TSHB—hypothyroidism	1.23e-05	0.000684	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TSHB—hypothyroidism	1.16e-05	0.000645	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TSHB—hypothyroidism	1.15e-05	0.000639	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.13e-05	0.000625	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.11e-05	0.000617	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.1e-05	0.00061	CbGpPWpGaD
Sertraline—MAOA—Metabolism—POMC—hypothyroidism	1.04e-05	0.00058	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.04e-05	0.000575	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	1.03e-05	0.00057	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.01e-05	0.000562	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TSHB—hypothyroidism	9.84e-06	0.000546	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SLC5A5—hypothyroidism	9.45e-06	0.000525	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SLC5A5—hypothyroidism	9.23e-06	0.000512	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	8.77e-06	0.000487	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SLC5A5—hypothyroidism	8.7e-06	0.000483	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.65e-06	0.00048	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SLC5A5—hypothyroidism	8.62e-06	0.000479	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TSHB—hypothyroidism	7.59e-06	0.000422	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC5A5—hypothyroidism	7.37e-06	0.000409	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	6.77e-06	0.000376	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—POMC—hypothyroidism	6.55e-06	0.000363	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC5A5—hypothyroidism	5.69e-06	0.000316	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—POMC—hypothyroidism	4.95e-06	0.000275	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—POMC—hypothyroidism	4.83e-06	0.000268	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—POMC—hypothyroidism	4.55e-06	0.000253	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—POMC—hypothyroidism	4.51e-06	0.00025	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—POMC—hypothyroidism	3.85e-06	0.000214	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—POMC—hypothyroidism	2.97e-06	0.000165	CbGpPWpGaD
